Skip to main content
. 2017 Aug 17;16:138. doi: 10.1186/s12943-017-0709-5

Fig. 6.

Fig. 6

Effects of RhoC silencing on ABHD11-AS1-overexpressing ovarian carcinoma cells in vitro. RhoC silencing in ABHD11-AS1-overexpressing ovarian carcinoma cells resulted in a decrease in RhoC, p70s6k, MMP2, and BCL-xL expression